Morgan C. Frank - 30 Jun 2026 Form 4 Insider Report for Modular Medical, Inc. (MODD)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: MODD
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 13:21:24 UTC
Prior SEC filing: 09 Apr 2026
Source filing: View source filing
Reporting owner signature: Morgan C. Frank By: /s/ Morgan C. Frank

Key filing fact

Morgan C. Frank filed Form 4 for Modular Medical, Inc. (MODD) on 01 Jul 2026.

Key facts

This page summarizes Morgan C. Frank's Form 4 filing for Modular Medical, Inc. (MODD).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 13:21.

Change

Previous filing in this sequence was filed on 09 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001593072 Primary reporting owner

FRANK MORGAN C.

Relationship: Director, 10%+ Owner
Address: 2 CALLE CANDINA, #1701, SAN JUAN
Signature: Morgan C. Frank By: /s/ Morgan C. Frank
Signature date: 01 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares: +62
Change %
Price
Shares after: 62
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62
Exercise price: $4.88
Footnotes: F1, F2

MODD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares: +250
Change %: +403%
Price
Shares after: 312
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250
Exercise price: $4.88
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

Footnote F2

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."